PITTSBURGH, Aug. 30, 2021 /PRNewswire/ -- Viatris Inc. /zigman2/quotes/209413137/composite VTRS -2.30% today announced the company will take part in a virtual fireside chat at Citi's 16th Annual BioPharma Conference on Friday, September 10, 2021. Chief Executive Officer Michael Goettler and President Rajiv Malik will answer questions about the company at 11:35 a.m. ET.
Interested parties can access a live webcast of the event at investor.viatris.com . An archived version also will be available following the live event and can be accessed at the same location for a limited time.
Viatris Inc. /zigman2/quotes/209413137/composite VTRS -2.30% is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway [®] . Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of more than 40,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com , and connect with us on Twitter at @ViatrisInc , LinkedIn and YouTube .
SOURCE Viatris Inc.
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.
Copyright (C) 2021 PR Newswire. All rights reserved